2. Gene
  3. Tat - tyrosine aminotransferase Gene

Tat - tyrosine aminotransferase Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

基因 ID: 24813 | 基因类型: protein coding

关于 Tat

功能概要

Enables L-tyrosine:2-oxoglutarate aminotransferase activity and amino acid binding activity. Involved in several processes, including response to dexamethasone; response to mercury ion; and response to oxidative stress. Located in mitochondrion. Human ortholog(s) of this gene implicated in tyrosinemia and tyrosinemia type II. Orthologous to human TAT (tyrosine aminotransferase). [provided by Alliance of Genome Resources, Apr 2022]

Tat 基因产物(1)

mRNA Protein Name
NM_012668.2 NP_036800.1 tyrosine aminotransferase
基因本体论
  • 分子功能
  • 生物过程
分子功能 GO 注释 逻辑证据 参考文献 来源
enables L-tyrosine-2-oxoglutarate transaminase activity IDA
IDA: 通过直接分析推断
12717026 RGD
enables amino acid binding IDA
IDA: 通过直接分析推断
12717026 RGD
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in amino acid metabolic process IDA
IDA: 通过直接分析推断
12717026 RGD
involved in response to dexamethasone IEP
IEP: 通过表达模式推断
27856527 RGD
involved in response to glucocorticoid IDA
IDA: 通过直接分析推断
16307467 RGD
involved in response to mercury ion IDA
IDA: 通过直接分析推断
16307467 RGD
involved in response to organic cyclic compound IDA
IDA: 通过直接分析推断
15755314 RGD
involved in response to oxidative stress IDA
IDA: 通过直接分析推断
16335249 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

tyrosine aminotransferase

L-tyrosine:2-oxoglutarate aminotransferase

相关产品

Approval
生物活性分子 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B2224 Thiamine disulfide Inhibitor 99.54% 否
Clinical Phase
生物活性分子 (5)
目录号 产品名 作用方式
纯度 Phase
HY-P0117 Tat-NR2B9c Inhibitor 99.77% Phase 3
HY-142118 Trabedersen Inhibitor 90.45% Phase 3
HY-P4056 CIGB-300 / Phase 3
HY-19149 Ro24-7429 99.89% Phase 2
HY-148130 Rugonersen Activator 91.12% Phase 1
Pre-clinical Phase
生物活性分子 (119)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P4108 TAT-HA2 Fusion Peptide 99.69% 否
HY-P2260 Tat-beclin 1 99.93% 否
HY-P5307 Peptide A5K 99.08% 否
HY-P1136C TAT-Gap19 TFA 99.41% 否
HY-P5381 gp91 ds-tat Inhibitor 98.27% 否
HY-P1136B TAT-Gap19 99.47% 否
HY-P0281A TAT TFA 98.85% 否
HY-P1420 TAT-cyclo-CLLFVY Inhibitor 98.79% 否
HY-109042 Relacorilant Antagonist 99.12% 是
HY-P2280 TAT-P110 Inhibitor 99.87% 否
HY-P0282A TAT peptide TFA 99.65% 否
HY-126428 ZL0580 99.26% 否
HY-P3432 DfTat 98.06% 否
HY-P10638 TAT-CN21 Inhibitor 99.90% 否
HY-P1491 HIV-1 TAT (48-60) 99.80% 否
HY-P1575 TAT (48-57) 98.23% 否
HY-P0117A Tat-NR2B9c TFA Inhibitor 99.67% 否
HY-P1801A Cys-TAT(47-57) TFA 98.04% 否
HY-P1328 TAT-14 Activator 99.66% 否
HY-P2259 TAT-GluA2 3Y Inhibitor 99.95% 否
HY-P2260B Tat-beclin 1 scrambled 99.01% 否
HY-W104477 3-Fluoro-L-tyrosine 99.73% 否
HY-P10438 TAT-Braftide Inhibitor 99.52% 否
HY-P2500 (Arg)9, FAM-labeled 99.83% 否
HY-P0281 TAT 99.92% 否
HY-P2260C Tat-beclin 1 scrambled TFA 98.54% 否
HY-P3429A SAMβA TFA Inhibitor 99.13% 否
HY-P2467 Biotin-TAT (47-57) 98.56% 否
HY-P10436 Braftide Inhibitor 99.68% 否
HY-P2307 Tat-NR2Baa 96.89% 否
HY-P4106A Tat-GluR23Y, scrambled TFA 99.47% 否
HY-P4114 TAT-NSF700scr 95.17% 否
HY-P5754B TAT-NEP1-40 acetate Inhibitor 94.33% 否
HY-P0282 TAT peptide / 否
HY-P10358 TAT-CBD3A6K 98.26% 否
HY-P5117 TAT-CIRP Inhibitor 98.32% 否
HY-P5320 TAT-BH4 (Bcl-xL) Inhibitor / 否
HY-115828 APA-APA-MPO dihydrochloride / 否
HY-115829 APA-H-MPO hydrochloride / 否
HY-148412 Monarsen Inhibitor / 否
HY-156372 AChE-IN-44 Inhibitor / 否
HY-172279 DSPE-PEG1000-TAT / 否
HY-172279A DSPE-PEG2000-TAT / 否
HY-172279B DSPE-PEG3000-TAT / 否
HY-172279C DSPE-PEG3400-TAT / 否
HY-172682 DSPE-PEG5000-VIP / 否
HY-P10048 TAT-JIP Inhibitor / 否
HY-P10049 TAT-TCL1-Akt-in Inhibitor / 否
HY-P10074 TAT-MEK1 Inhibitor / 否
HY-P10076 TAT-JBD20 Inhibitor / 否
HY-P10106 TAT-PAK18 inhibitory peptide Inhibitor / 否
HY-P10107 TAT-PAK18 R192A Control / 否
HY-P10110 retro-inverso TAT-Beclin 1 (D-amino acid) Inducer / 否
HY-P10255 K90-114TAT Inhibitor / 否
HY-P10275 Tat-NTS peptide Inhibitor / 否
HY-P10357 TAT-CBD3 Inhibitor / 否
HY-P10359 TAT-QFNP12 Inhibitor / 否
HY-P10360 Tat-βsyn-degron Degrader / 否
HY-P10445 TAT-PiET Inhibitor / 否
HY-P10446 TAT-PiET-PROTAC Inhibitor / 否
HY-P10464 Tat-AKAP79 (326-336) Inhibitor / 否
HY-P10465 TRPV1-Tat Antagonist / 否
HY-P10638A TAT-CN21 (scrambled) Control / 否
HY-P10797 TAT-N24 Inhibitor / 否
HY-P10821 Myr-Tat-PKCβII Inhibitor / 否
HY-P10824 RI-OR2-TAT Inhibitor / 否
HY-P10839 NBD peptide Inhibitor / 否
HY-P10852 TAT-MKK3b Inhibitor / 否
HY-P10854 TAT-N15 Inhibitor / 否
HY-P10966 Tat-IKIP (46-60) Inhibitor / 否
HY-P10977 Tat-ASIC1a (1-20) (mouse, rat) Inhibitor / 否
HY-P10995 TAT-327 / 否
HY-P11000 INF7TAT / 否
HY-P1328A TAT-14 TFA Activator / 否
HY-P1420A TAT-cyclo-CLLFVY TFA Inhibitor / 否
HY-P1575A TAT (48-57) (TFA) / 否
HY-P1801 Cys-TAT(47-57) / 否
HY-P1908 sgp91 ds-tat Peptide 2, scrambled Inhibitor / 否
HY-P2260A Tat-beclin 1 TFA / 否
HY-P2298 TAT-P4-(DATC5)2 Inhibitor / 否
HY-P2298A TAT-P4-(DATC5)2 TFA / 否
HY-P2307A Tat-NR2Baa TFA / 否
HY-P2493 (Cys47)-HIV-1 tat Protein (47-57) / 否
HY-P3429 SAMβA Inhibitor / 否
HY-P3730 Cdk2/Cyclin Inhibitory Peptide I Inhibitor / 否
HY-P3731 Cdk2/Cyclin Inhibitory Peptide II Inhibitor / 否
HY-P4101 Cys(Npys)-TAT (47-57) / 否
HY-P4105 TAT (47-57), TAMRA-labeled / 否
HY-P4106 Tat-GluR23Y, scrambled / 否
HY-P4110 TAT-NSF222 Fusion Peptide Inhibitor / 否
HY-P4122 TAT (47-57), FAM-labeled / 否
HY-P4123 TAT (47-57) GGG-Cys(Npys) / 否
HY-P4125 FITC-LC-TAT (47-57) / 否
HY-P5277 TAT-GluN2BCTM Degrader / 否
HY-P5307A Peptide A5K acetate / 否
HY-P5320A TAT-BH4 (Bcl-xL) (TFA) Inhibitor / 否
HY-P5384 sgp91 ds-tat Inhibitor / 否
HY-P5395 TAT-GluR23A Fusion Peptide Inhibitor / 否
HY-P5754 TAT-NEP1-40 Inhibitor / 否
HY-P5754A TAT-NEP1-40 TFA Inhibitor / 否
HY-P5874 Myr-TAT-CBD3 Inhibitor / 否
HY-P5883 TAT-M2NX Inhibitor / 否
HY-P5891 TAT-SAMβA Antagonist / 否
HY-P5947 Tat-HA-NR2B9c / 否
HY-RS01124 ATAT1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS14225 TAT Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-10281 YM-60828 methanesulfonate Inhibitor / 否
HY-119120 JTK-101 Inhibitor / 否
HY-D2441 TAT-PEG-Cy3 / 否
HY-P10358A TAT-CBD3A6K acetate 99.76% 否
HY-P10401 TAT-GluR6-9c Antagonist / 否
HY-P10405 TAT-D1 peptide Antagonist / 否
HY-P4056A CIGB-300 acetate / 否
HY-RS16581 Tat Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS19656 Atat1 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23015 Tat Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26149 Atat1 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-P3431 VSGLNPSLWSIFGLQFILLWLVSGSRHYLW Antagonist / 否
HY-P3431A VSGLNPSLWSIFGLQFILLWLVSGSRHYLW TFA Antagonist / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Tat NCBI NCBI:6898
Canis familiaris Tat NCBI NCBI:479665
Felis catus Tat NCBI NCBI:101080599
Macaca fascicularis Tat NCBI NCBI:102144775
Mus musculus Tat NCBI NCBI:234724
Susscrofa domestica Tat NCBI
Macaca mulatta Tat NCBI NCBI:708005
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z